Internal Medicine, Critical Care Medicine · Orlando, FL
NPI
1942431135
Since 2009
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2501 N Orange Ave Ste 402
Orlando, FL, 32804
Phone (407) 303-3638
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
477 services
Medicare patients, 2024
232
Average age 69
Drug cost, 2024
$9.5M
1,637 prescriptions
Company payments, 2025
$97K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Debabrata Bandyopadhyay was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 116 times for 105 patients. In total Debabrata Bandyopadhyay billed 477 services in 17 codes, and Medicare paid $40K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 116 | 105 | $12.77 | $1,482 |
| 99215 Office E&M - Established | Facility | 106 | 90 | $104.87 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 75 | 46 | $91.37 | $6,853 |
| 99291 Critical Care E&M | Facility | 64 | 30 | $162.14 | $10K |
| 99214 Office E&M - Established | Facility | 60 | 56 | $70.69 | $4,242 |
| 99205 Office E&M - New | Facility | 24 | 24 | $130.32 | $3,128 |
| 93451 Percutaneous Transcatheterization | Facility | 11 | 11 | $78.03 | $858 |
By year: 2022 $84K for 746 services; 2023 $63K for 550 services; 2024 $40K for 477 services.
Medicare prescription drug claims, 2024
In 2024, the drug Debabrata Bandyopadhyay prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 505 prescriptions and refills. In total Debabrata Bandyopadhyay wrote 1,637 Medicare prescriptions that cost $9.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 505 | 515 | 82 | $6.4M |
| Mycophenolate Mofetil Generic | 203 | 376 | 48 | $90K |
| Prednisone Generic | 120 | 258 | 43 | $1,034 |
| Pirfenidone Generic | 114 | 120 | 29 | $198K |
| Sildenafil Citrate Generic | 51 | 79 | 14 | $7,574 |
| Adempas Riociguat | 46 | 46 | Under 11 | $606K |
| Opsumit Macitentan | 44 | 44 | Under 11 | $541K |
| Methotrexate Methotrexate Sodium | 40 | 66 | 11 | $642 |
| Omeprazole Generic | 27 | 73 | 14 | $486 |
| Tyvaso Dpi Treprostinil | 26 | 26 | Under 11 | $626K |
| Azathioprine Generic | 25 | 59 | Under 11 | $1,352 |
| Uptravi Selexipag | 25 | 25 | Under 11 | $629K |
| Pantoprazole Sodium Generic | 24 | 68 | 12 | $471 |
| Hydroxychloroquine Sulfate Generic | 24 | 46 | Under 11 | $513 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 24 | 24 | Under 11 | $11K |
Brand drugs: 787 claims; generic drugs: 850 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Debabrata Bandyopadhyay $97K ($97K in general payments such as food, travel and fees) from 7 companies. The largest payer was United Therapeutics Corporation with $39K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.